These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35939205)

  • 1. MedDRA Labeling Groupings to Improve Safety Communication in Product Labels.
    Große-Michaelis I; Proestel S; Rao RM; Dillman BS; Bader-Weder S; Macdonald L; Gregory W
    Ther Innov Regul Sci; 2023 Jan; 57(1):1-6. PubMed ID: 35939205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardised MedDRA queries: their role in signal detection.
    Mozzicato P
    Drug Saf; 2007; 30(7):617-9. PubMed ID: 17604415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).
    Brown EG
    Drug Saf; 2003; 26(3):145-58. PubMed ID: 12580645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.
    Bousquet C; Lagier G; Lillo-Le Louët A; Le Beller C; Venot A; Jaulent MC
    Drug Saf; 2005; 28(1):19-34. PubMed ID: 15649103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical dictionary for regulatory activities (MedDRA).
    Brown EG; Wood L; Wood S
    Drug Saf; 1999 Feb; 20(2):109-17. PubMed ID: 10082069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.
    Brown EG
    Drug Saf; 2002; 25(6):445-52. PubMed ID: 12071782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MedDRA and pharmacovigilance: a complex and little-evaluated tool.
    Prescrire Int; 2016 Oct; 25(175):247-250. PubMed ID: 30645835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploitation of semantic methods to cluster pharmacovigilance terms.
    Dupuch M; Dupuch L; Hamon T; Grabar N
    J Biomed Semantics; 2014; 5():18. PubMed ID: 24739596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating a Framework for Coding Patient-Reported Health Information to the Medical Dictionary for Regulatory Activities Terminology: An Evaluative Study.
    Brajovic S; Blaser DA; Zisk M; Caligtan C; Okun S; Hall M; Pamer CA
    JMIR Med Inform; 2018 Aug; 6(3):e42. PubMed ID: 30131314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using MedDRA: implications for risk management.
    Brown EG
    Drug Saf; 2004; 27(8):591-602. PubMed ID: 15154830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Automated grouping of terms associated to cardiac valve fibrosis in MedDRA].
    Asfari H; Souvignet J; Lillo-Le Louët A; Trombert B; Jaulent MC; Bousquet C
    Therapie; 2016 Dec; 71(6):541-552. PubMed ID: 27692980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating MedDRA-to-ICD terminology mappings.
    Zhang X; Feng Y; Li F; Ding J; Tahseen D; Hinojosa E; Chen Y; Tao C
    BMC Med Inform Decis Mak; 2024 Feb; 23(Suppl 4):299. PubMed ID: 38326827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of MedDRA
    Kralova K; Wilson CA; Richebourg N; D'souza J
    Drug Saf; 2023 May; 46(5):501-507. PubMed ID: 37087705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grouping pharmacovigilance terms with semantic distance.
    Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
    Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.